Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns

Overview of attention for article published in Journal of Nuclear Medicine, December 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 12 X users

reddit: 1 Redditor

Readers on

mendeley: 91 Mendeley

So far, Altmetric has seen 13 X posts from 12 X users, with an upper bound of 9,164 followers.

RT @MIRimaging: MIR Director Richard Wahl, MD, Assistant Professor Amir Iravani, MD (@DrAIravani), and colleagues outline the knowns and un…

Excellent paper in a highly engaging supplement issue of @JournalofNucMed. A must read for those engaged, or otherwise interested in radiopharmaceutical therapies. @SNM_MI @nmroacnm @MIRimaging #nucmed

MIR Director Richard Wahl, MD, Assistant Professor Amir Iravani, MD (@DrAIravani), and colleagues outline the knowns and unknowns of radiopharmaceutical dose–toxicity relationships in @JournalofNucMed. #nucmed https://t.co/yNxGeBhRAj

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 9 additional X posts.